within Pharmacolibrary.Drugs.ATC.D;

model D08AX07
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D08AX07</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sodium hypochlorite is a strong oxidizing agent primarily used as a disinfectant and antiseptic. It is widely utilized for cleaning wounds, sterilizing, and as a bleaching agent. It is not used systemically in medical practice and has no approved use as a systemic drug in modern medicine. Its use is limited to topical or external applications and dental root canal irrigation.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or clinical studies have reported systemic pharmacokinetic parameters for sodium hypochlorite in humans. The substance is highly reactive, used topically, and is not intended for or suitable for systemic administration, absorption, or metabolism studies.</p><h4>References</h4><ol><li><p>Belloni Fortina, A, &amp; Neri, L (2015). Antibiotic therapy in the management of atopic dermatitis. <i>Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia</i> 150(3) 321–325. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25786482/&quot;>https://pubmed.ncbi.nlm.nih.gov/25786482</a></p></li><li><p>White, RJ, et al., &amp; Kingsley, A (2006). Topical antimicrobials in the control of wound bioburden. <i>Ostomy/wound management</i> 52(8) 26–58. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16896238/&quot;>https://pubmed.ncbi.nlm.nih.gov/16896238</a></p></li><li><p>Cooper, ML, et al., &amp; Hansbrough, JF (1991). The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. <i>The Journal of trauma</i> 31(6) 775–784. DOI:<a href=&quot;https://doi.org/10.1097/00005373-199106000-00007&quot;>10.1097/00005373-199106000-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2056541/&quot;>https://pubmed.ncbi.nlm.nih.gov/2056541</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D08AX07;
